XT
EBS icon

XTX Topco’s Emergent Biosolutions EBS Stock Holding History

XTX Topco’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
+14,674
New +$123K ﹤0.01% 3456
2025
Q3 		– Sell
-27,237
Closed -$174K – 2726
2025
Q2 		$174K Sell
27,237
-58,575
-68% -$335K 0.01% 1752
2025
Q1 		$417K Buy
+85,812
New +$710K 0.02% 1159
2024
Q3 		– Sell
-62,764
Closed -$428K – 2207
2024
Q2 		$428K Buy
62,764
+43,028
+218% +$185K 0.04% 736
2024
Q1 		$49.9K Buy
+19,736
New +$44.5K 0.01% 1475
2023
Q4 		– Sell
-31,462
Closed -$107K – 1716
2023
Q3 		$107K Buy
31,462
+17,636
+128% +$97.8K 0.02% 1175
2023
Q2 		$102K Buy
+13,826
New +$128K 0.02% 1163
2023
Q1 		– Sell
-15,307
Closed -$181K – 1375
2022
Q4 		$181K Buy
+15,307
New +$237K 0.04% 882
2021
Q2 		– Sell
-4,840
Closed -$450K – 871
2021
Q1 		$450K Buy
+4,840
New +$496K 0.22% 126

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

XTX Topco's EBS Position: Q2 2026 in Review

XTX Topco opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 14,674 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #3456 among its holdings. This is a return to the name: XTX Topco previously reported a position in EBS as recently as Q2 2025.

XTX Topco first reported a position in EBS in Q1 2021 and has held it in 9 quarters since. The position peaked at $450K in Q1 2021. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • XTX Topco held 14,674 shares of Emergent Biosolutions worth $123K as of Q2 2026.
  • Emergent Biosolutions was a new XTX Topco position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3456 holding.
  • XTX Topco first reported a position in Emergent Biosolutions in Q1 2021 and has held it in 9 quarters since.
  • XTX Topco's Emergent Biosolutions position peaked at $450K in Q1 2021.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.